Achieve Life Sciences (NASDAQ: ACHV) awards options and RSUs to director
Rhea-AI Filing Summary
Achieve Life Sciences director Nancy R. Phelan received new equity awards. She was granted stock options for 25,000 shares of common stock at an exercise price of $6.18 per share, expiring on July 27, 2036. These options vest 100% on the earlier of July 27, 2027 or immediately before the company’s 2027 annual stockholders’ meeting, subject to her continued service. She also received 16,700 Restricted Stock Units, each representing a contingent right to receive one share of common stock, with the same cliff-vesting schedule and service condition.
Positive
- None.
Negative
- None.
Insider Trade Summary
2 transactions reported
Mixed
2 txns
Insider
Phelan Nancy R.
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (right to buy) F1 | 25,000 | $0.00 | $0.00 |
| Grant/Award | Restricted Stock Unit (RSU) F2, F3 | 16,700 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (right to buy) — 25,000 shares (Direct);
Restricted Stock Unit (RSU) — 16,700 shares (Direct)
Footnotes (3)
- F1. The options vest 100% on the earlier of July 27, 2027 or the date immediately prior to the Issuer's 2027 annual meeting of stockholders, subject to the Reporting Person's provision of service to the Issuer on the vesting date.
- F2. Each RSU represents a contingent right to receive one share of the Issuer's common stock at settlement.
- F3. Pursuant to the terms of the RSU, the shares underlying the RSU vest 100% on the earlier of July 27, 2027 or the date immediately prior to the Issuer's 2027 annual meeting of stockholders, subject to the Reporting Person's provision of service to the Issuer on the vesting date.
Key Figures
Stock options granted: 25,000 shares
Option exercise price: $6.18 per share
Option expiration date: 2036-07-27
+5 more
8 metrics
Stock options granted
25,000 shares
Stock Option (right to buy) grant to director Nancy R. Phelan on 2026-07-27
Option exercise price
$6.18 per share
Exercise price for 25,000 stock options granted on 2026-07-27
Option expiration date
2036-07-27
Expiration date of Nancy R. Phelan’s 25,000 stock options
RSUs granted
16,700 units
Restricted Stock Unit grant to Nancy R. Phelan on 2026-07-27
Option vesting date trigger
July 27, 2027
Cliff vesting on earlier of July 27, 2027 or date before 2027 annual meeting
RSU vesting date trigger
July 27, 2027
RSUs vest 100% on earlier of July 27, 2027 or date before 2027 annual meeting
Options held after grant
25,000 options
Total stock options reported following the transaction
RSUs held after grant
16,700 RSUs
Total RSUs reported following the transaction
Key Terms
Stock Option (right to buy), Restricted Stock Unit (RSU), contingent right, vest 100%, +1 more
5 terms
Stock Option (right to buy) financial
"security_title: Stock Option (right to buy)"
Restricted Stock Unit (RSU) financial
"security_title: Restricted Stock Unit (RSU)"
A restricted stock unit (RSU) is a promise from a company to give an employee company shares (or cash equal to their value) at a future date if certain conditions are met, such as staying with the company or hitting performance targets. For investors, RSUs matter because when they convert into actual shares they increase the number of shares available and can create selling pressure as employees cash out—think of them as a future paycheck paid in company stock.
contingent right financial
"Each RSU represents a contingent right to receive one share"
vest 100% financial
"The options vest 100% on the earlier of July 27, 2027"
annual meeting of stockholders financial
"immediately prior to the Issuer's 2027 annual meeting of stockholders"
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What equity awards did Achieve Life Sciences (ACHV) director Nancy R. Phelan receive?
Nancy R. Phelan received a grant of 25,000 stock options and 16,700 Restricted Stock Units (RSUs). Both awards are tied to Achieve Life Sciences common stock and represent part of her director equity-based compensation.
What is the exercise price of Nancy Phelan’s new stock options at ACHV?
The new stock options granted to Nancy R. Phelan have an exercise price of $6.18 per share. She received options on 25,000 shares of Achieve Life Sciences common stock with this strike price.
When do Nancy Phelan’s Achieve Life Sciences stock options and RSUs vest?
Both the stock options and RSUs vest 100% on the earlier of July 27, 2027 or immediately before Achieve Life Sciences’ 2027 annual stockholders’ meeting, provided Nancy R. Phelan continues to serve the company through the vesting date.
What does each RSU granted to Nancy Phelan by ACHV represent?
Each RSU granted to Nancy R. Phelan represents a contingent right to receive one share of Achieve Life Sciences common stock upon settlement. She was awarded 16,700 RSUs under these terms.
What are Nancy Phelan’s post-grant holdings from this ACHV Form 4 filing?
Following these awards, Nancy R. Phelan holds 25,000 stock options and 16,700 RSUs as reported positions. These figures reflect the equity awards covered in this specific filing only.
When do Nancy Phelan’s Achieve Life Sciences stock options expire?
The stock options granted to Nancy R. Phelan expire on July 27, 2036. She may exercise up to 25,000 options at an exercise price of $6.18 per share before this expiration date, subject to vesting.